GSK3B and esophageal squamous cell carcinoma: Reports indicate that ribosomal S6 protein kinase 4 activates the β‐catenin signaling pathway by phosphorylating GSK‐3β directly, leading to the enhancement of CSC characteristics and resistance to radiation in ESCC.42